Investigation of pathways regulating early antiangiogenic response to bevacizumab given prior to neoadjuvant breast cancer chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2010
At a glance
- Drugs Bevacizumab (Primary)
- Indications Advanced breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 08 Jun 2010 Thrity-one patients have been recruited to date, according to information reported at ASCO 2010.
- 08 Jun 2010 New trial record